leon-nanodrugs is a nanotechnology-based drug development company focused on reformulations and reinventions of established drugs. Based on its patented MJR-Nanotechnology-Platform leon-nanodrugs has a leading position in the development of “supergenerics” and “high-barrier-generics”.
The company provides a 360 degree service range from scientific concept to GMP manufacturing for pharmaceutical companies all over the world.
The business concept includes contract development as well as co-development opportunities. Within a very short development time of three to four years leon-nanodrugs offers a completely new way of product innovations in the worldwide generic market with high return on invest.